CRYO-CELL INTERNATIONAL, INC. (CCEL) Cash and securities
- Total cash · latest quarter (USD): Value $3.16M; Formula and calculation Cash and cash equivalents plus current marketable securities. Period ending 2026-05-31..
- Cash per share · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities / reported quarter-end common shares. Period ending 2026-05-31..
Cash and securities
Overview →Financial period ending 2026-05-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total cash · latest quarter (USD) | $3.16M | Cash and cash equivalents plus current marketable securities. Period ending 2026-05-31. $507.30K + $2.65M ≈ $3.16M |
| Cash per share · latest quarter | (m) | Cash and cash equivalents plus current marketable securities / reported quarter-end common shares. Period ending 2026-05-31. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash and equivalents | 507.30K USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | 2.65M USD | Marketable Securities, Current |
| Cash and current securities | 3.16M USD | Cash and Cash Equivalents, at Carrying Value · Marketable Securities, Current |
| Quarter-end shares | (m) | Common Stock, Shares, Outstanding |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total cash | Cash per share | Cash and equivalents (USD) | Short-term securities (USD) | Quarter-end shares (shares) |
|---|---|---|---|---|---|
| 2026-05-31 | $3.16M | (m) | $507.30K | $2.65M | (m) |
| 2026-02-28 | $2.90M | (m) | $249.67K | $2.65M | (m) |
| 2025-11-30 | $3.30M | (m) | $319.03K | $2.98M | (m) |
| 2025-08-31 | $3.22M | (m) | $265.21K | $2.96M | (m) |
| 2025-05-31 | $4.43M | (m) | $137.49K | $4.29M | (m) |
| 2025-02-28 | $3.48M | (m) | $223.12K | $3.26M | (m) |
| 2024-11-30 | $3.50M | (m) | $560.96K | $2.94M | (m) |
| 2024-08-31 | $2.13M | (m) | $197.44K | $1.93M | (m) |
| 2024-05-31 | $1.53M | (m) | $469.19K | $1.06M | (m) |
| 2024-02-29 | $979.59K | (m) | $247.11K | $732.48K | (m) |
| 2023-11-30 | $980.25K | (m) | $406.07K | $574.18K | (m) |
| 2023-08-31 | $1.21M | (m) | $584.00K | $623.49K | (m) |
| 2023-05-31 | $1.69M | (m) | $1.12M | $568.18K | (m) |
| 2023-02-28 | $2.21M | (m) | $1.37M | $840.28K | (m) |
| 2022-11-30 | $1.72M | (m) | $1.70M | $17.62K | (m) |
| 2022-08-31 | $2.96M | (m) | $2.92M | $38.70K | (m) |
| 2022-05-31 | $2.87M | (m) | $2.80M | $63.13K | (m) |
| 2022-02-28 | $2.62M | (m) | $2.14M | $472.37K | (m) |
| 2021-11-30 | $8.34M | (m) | $8.26M | $75.41K | (m) |
| 2021-08-31 | $7.77M | (m) | $7.70M | $74.12K | (m) |
| 2021-05-31 | $8.02M | (m) | $7.95M | $73.39K | (m) |
| 2021-02-28 | $11.36M | (m) | $11.28M | $85.90K | (m) |
| 2020-11-30 | $10.45M | (m) | $10.36M | $88.48K | (m) |
| 2020-08-31 | $8.17M | (m) | $8.11M | $62.72K | (m) |
| 2020-05-31 | $9.32M | (m) | $8.42M | $905.43K | (m) |
| 2020-02-29 | $9.37M | (m) | $8.42M | $959.00K | (m) |
| 2019-11-30 | $7.45M | (m) | $6.54M | $904.05K | (m) |
| 2019-08-31 | $8.21M | (m) | $7.34M | $874.69K | (m) |
| 2019-05-31 | $7.31M | (m) | $6.47M | $839.81K | (m) |
| 2019-02-28 | $7.88M | (m) | $7.08M | $808.51K | (m) |
| 2018-11-30 | $6.92M | (m) | $6.04M | $875.69K | (m) |
| 2018-08-31 | $7.99M | (m) | $7.04M | $949.76K | (m) |
| 2018-05-31 | $7.11M | (m) | $6.54M | $572.61K | (m) |
| 2018-02-28 | $7.58M | (m) | $6.99M | $586.23K | (m) |
| 2017-11-30 | $6.72M | (m) | $6.28M | $439.32K | (m) |
| 2017-08-31 | $5.19M | (m) | $4.67M | $523.88K | (m) |
| 2017-05-31 | $5.18M | (m) | $4.70M | $478.34K | (m) |
| 2017-02-28 | $3.98M | (m) | $3.51M | $476.46K | (m) |
| 2016-11-30 | $4.12M | (m) | $3.50M | $624.22K | (m) |
| 2016-08-31 | $2.66M | (m) | $2.03M | $630.02K | (m) |
| 2016-05-31 | $5.19M | (m) | $4.52M | $673.78K | (m) |
| 2016-02-29 | $4.20M | (m) | $3.58M | $617.11K | (m) |
| 2015-12-03 | (m) | (m) | $4.15M | (m) | (m) |
| 2015-11-30 | $4.76M | (m) | $4.15M | $610.42K | (m) |
| 2015-08-31 | $3.18M | (m) | $2.72M | $460.51K | (m) |
| 2015-05-31 | $4.45M | (m) | $3.91M | $532.37K | (m) |
| 2015-02-28 | $3.65M | (m) | $3.55M | $98.26K | (m) |
| 2014-11-30 | $3.38M | (m) | $3.28M | $102.67K | (m) |
| 2014-08-31 | $3.57M | (m) | $3.45M | $122.66K | (m) |
| 2014-05-31 | $3.54M | (m) | $3.40M | $140.56K | (m) |
| 2014-02-28 | (m) | (m) | $3.24M | (m) | (m) |
| 2013-12-01 | (m) | (m) | $3.93M | (m) | (m) |
| 2013-11-30 | (m) | (m) | $3.93M | (m) | (m) |
| 2013-08-31 | (m) | (m) | $3.73M | (m) | (m) |
| 2013-05-31 | (m) | (m) | $2.90M | (m) | (m) |
| 2013-02-28 | (m) | (m) | $2.86M | (m) | (m) |
| 2012-11-30 | (m) | (m) | $2.68M | (m) | (m) |
| 2012-08-31 | (m) | (m) | $2.71M | (m) | (m) |
| 2012-05-31 | (m) | (m) | $2.80M | (m) | (m) |
| 2012-02-29 | (m) | (m) | $4.32M | (m) | (m) |
| 2011-11-30 | $7.31M | (m) | $6.31M | $1.00M | (m) |
| 2011-08-31 | $6.88M | (m) | $5.87M | $1.00M | (m) |
| 2011-05-31 | (m) | (m) | $8.21M | (m) | (m) |
| 2011-02-28 | (m) | (m) | $8.38M | (m) | (m) |
| 2010-11-30 | $9.50M | (m) | $8.37M | $1.13M | (m) |
| 2010-08-31 | (m) | (m) | $7.88M | (m) | (m) |
| 2009-11-30 | (m) | (m) | $6.85M | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |